A novel concept in mucosal adjuvanticity: the CTA1-DD adjuvant is a B cell-targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit.

Source:http://linkedlifedata.com/resource/pubmed/id/9682972

Download in:

View as

General Info

PMID
9682972